NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
16.02
-0.19 (-1.17%)
At close: Jul 18, 2025, 4:00 PM
16.50
+0.48 (3.00%)
After-hours: Jul 18, 2025, 5:47 PM EDT

Company Description

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.

The company’s TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer.

NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.

NovoCure Limited
NovoCure logo
CountrySwitzerland
Founded2000
IPO DateOct 2, 2015
IndustryMedical Devices
SectorHealthcare
Employees1,488
CEOAshley Cordova

Contact Details

Address:
Neuhofstrasse 21
Baar, 6340
Switzerland
Websitenovocure.com

Stock Details

Ticker SymbolNVCR
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001645113
CUSIP NumberG6674U108
ISIN NumberJE00BYSS4X48
SIC Code3841

Key Executives

NamePosition
Ashley CordovaChief Executive Officer and Director
William F. DoyleExecutive Chairman
Barak Ben-AryeGeneral Counsel
Dr. Uri Weinberg M.D., Ph.D.Chief Innovation Officer
Frank LeonardExecutive Vice President and President of Novocure Oncology
Christoph BrackmannChief Financial Officer
Mukund ParavasthuChief Operating Officer
Ingrid GoldbergVice President of Investor Relations
Michael PuriChief Human Resources Officer
Dr. Nicolas Leupin M.B.A., M.D., Ph.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Jul 7, 2025SCHEDULE 13G/AFiling
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 30, 2025S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments
Jun 6, 20258-KCurrent Report
Jun 2, 2025144Filing